Financial results - VEXMED PHARM SRL

Financial Summary - Vexmed Pharm Srl
Unique identification code: 33358944
Registration number: J13/1378/2014
Nace: 8129
Sales - Ron
11.298
Net Profit - Ron
933
Employees
1
Open Account
Company Vexmed Pharm Srl with Fiscal Code 33358944 recorded a turnover of 2024 of 11.298, with a net profit of 933 and having an average number of employees of 1. The company operates in the field of Alte activitati de curatenie having the NACE code 8129.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Vexmed Pharm Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 0 0 8.646 51.592 6.658 0 4.123 6.911 10.809 11.298
Total Income - EUR 0 0 23.259 51.640 6.670 6 4.123 6.911 10.809 11.298
Total Expenses - EUR 26.673 14.404 13.784 46.526 7.655 3.167 4.931 4.801 10.352 10.188
Gross Profit/Loss - EUR -26.673 -14.404 9.475 5.114 -985 -3.161 -807 2.110 457 1.111
Net Profit/Loss - EUR -26.673 -14.404 7.757 3.566 -1.185 -3.161 -849 1.919 349 933
Employees 0 0 0 0 0 0 1 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 5.1%, from 10.809 euro in the year 2023, to 11.298 euro in 2024. The Net Profit increased by 586 euro, from 349 euro in 2023, to 933 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Vexmed Pharm Srl

Rating financiar

Financial Rating -
VEXMED PHARM SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Vexmed Pharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Vexmed Pharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Vexmed Pharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Vexmed Pharm Srl - CUI 33358944

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 24.543 14.552 4.769 -780 -765 -2 2.002 1.461 910 362
Current Assets 6.227 4.506 3.566 9.269 9.227 6.309 2.521 1.431 3.556 4.751
Inventories 0 0 0 2.714 2.661 0 263 264 322 59
Receivables 1.905 3.560 2.670 6.406 6.304 6.184 1.790 63 0 231
Cash 4.322 946 896 150 261 124 469 1.104 3.234 4.461
Shareholders Funds -26.628 -40.715 -32.269 -28.112 -28.751 -31.367 -31.520 -29.699 -29.260 -28.163
Social Capital 45 89 88 86 84 83 81 81 81 80
Debts 57.398 59.773 40.604 36.600 37.213 37.674 36.044 32.590 33.726 33.277
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8129 - 8129"
CAEN Financial Year 145
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 4.751 euro in 2024 which includes Inventories of 59 euro, Receivables of 231 euro and cash availability of 4.461 euro.
The company's Equity was valued at -28.163 euro, while total Liabilities amounted to 33.277 euro. Equity increased by 933 euro, from -29.260 euro in 2023, to -28.163 in 2024.

Risk Reports Prices

Reviews - Vexmed Pharm Srl

Comments - Vexmed Pharm Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.